Cole Hugh M 4
4 · Jounce Therapeutics, Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Cole Hugh M
Chief Business Officer
Transactions
- Award
Common Stock
2022-02-01+42,500→ 106,716 total - Award
Stock Option (Right to Buy)
2022-02-01+85,000→ 85,000 totalExercise: $7.56Exp: 2032-02-01→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The option will vest quarterly in 16 equal installments following January 1, 2022.